Fisher, Edward A.

Smooth Muscle Cell Reprogramming in Aortic Aneurysms

Chen, P.-Y., Qin, L., Li, G., Malagon-Lopez, J., Wang, Z., Bergaya, S., Gujja, S., Caulk, A. W., Murtada, S.-I., Zhang, X., et al. (2020) · Cell Stem Cell

Aortic aneurysm repair treatmentsAortic Disease and Treatment Approaches

Cited by 214

Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis

Seijkens, T. T. P., van Tiel, C. M., Kusters, P. J. H., Atzler, D., Soehnlein, O., Zarzycka, B., Aarts, S. A. B. M., Lameijer, M., Gijbels, M. J., Beckers, L., et al. (2018) · Journal of the American College of Cardiology

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 195

Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis

Lobatto, M. E., Fayad, Z. A., Silvera, S., Vucic, E., Calcagno, C., Mani, V., Dickson, S. D., Nicolay, K., Banciu, M., Schiffelers, R. M., et al. (2010) · Molecular Pharmaceutics

Atherosclerosis and Cardiovascular DiseasesNanoparticle-Based Drug Delivery

Cited by 170

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice

Goedeke, L., Salerno, A., Ramírez, C. M., Guo, L., Allen, R. M., Yin, X., Langley, S. R., Esau, C., Wanschel, A., Fisher, E. A., et al. (2014) · EMBO Molecular Medicine

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 145

Fish Oil for the Treatment of Cardiovascular Disease

Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z. (2010) · Cardiology in Review

Fatty Acid Research and HealthEdible Oils Quality and Analysis

Cited by 138

Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice

Weng, W., Li, L., van Bennekum, A. M., Potter, S. H., Harrison, E. H., Blaner, W. S., Breslow, J. L., & Fisher, E. A. (1999) · Biochemistry

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 135

N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes.

Wang, H., Chen, X., & Fisher, E. A. (1993) · Journal of Clinical Investigation

Fatty Acid Research and HealthCholesterol and Lipid Metabolism

Cited by 133

Huh-7 or HepG2 Cells: Which Is the Better Model for Studying Human Apolipoprotein-B100 Assembly and Secretion?

Meex, S. J. R., Andreo, U., Sparks, J. D., & Fisher, E. A. (2011) · Journal of Lipid Research

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 129

Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control

Pan, M., Maitin, V., Parathath, S., Andreo, U., Lin, S. X., Germain, C. S., Yao, Z., Maxfield, F. R., Williams, K. J., & Fisher, E. A. (2008) · Proceedings of the National Academy of Sciences

Autophagy in Disease and TherapyCholesterol and Lipid Metabolism

Cited by 128

Regression of Atherosclerosis Is Characterized by Broad Changes in the Plaque Macrophage Transcriptome

Feig, J. E., Vengrenyuk, Y., Reiser, V., Wu, C., Statnikov, A., Aliferis, C. F., Garabedian, M. J., Fisher, E. A., & Puig, O. (2012) · PLoS ONE

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 118

Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice

Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis

Advanced Glycation End Products researchAtherosclerosis and Cardiovascular Diseases

Cited by 109

Phospholipid Transfer Protein Deficiency Impairs Apolipoprotein-B Secretion from Hepatocytes by Stimulating a Proteolytic Pathway through a Relative Deficiency of Vitamin E and an Increase in Intracellular Oxidants

Jiang, X.-C., Li, Z., Liu, R., Yang, X. P., Pan, M., Lagrost, L., Fisher, E. A., & Williams, K. J. (2005) · Journal of Biological Chemistry

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 102

LXRα Regulates Macrophage Arginase 1 Through PU.1 and Interferon Regulatory Factor 8

Pourcet, B., Feig, J. E., Vengrenyuk, Y., Hobbs, A. J., Kepka-Lenhart, D., Garabedian, M. J., Morris, S. M., Fisher, E. A., & Pineda-Torra, I. (2011) · Circulation Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 97

Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low-density lipoprotein in HepG2 cells

Wong, S. H., Fisher, E. A., & Marsh, J. B. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc.

Fatty Acid Research and HealthLipid metabolism and biosynthesis

Cited by 91

Quantum Dot and Cy5.5 Labeled Nanoparticles to Investigate Lipoprotein Biointeractions via Förster Resonance Energy Transfer

Skajaa, T., Zhao, Y., van den Heuvel, D. J., Gerritsen, H. C., Cormode, D. P., Koole, R., van Schooneveld, M. M., Post, J. A., Fisher, E. A., Fayad, Z. A., et al. (2010) · Nano Letters

Quantum Dots Synthesis And PropertiesLipid Membrane Structure and Behavior

Cited by 76

Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis

Cormode, D. P., Chandrasekar, R., Delshad, A., Briley-Saebo, K. C., Calcagno, C., Barazza, A., Mulder, W. J. M., Fisher, E. A., & Fayad, Z. A. (2009) · Bioconjugate Chemistry

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 72

The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis

Skajaa, T., Cormode, D. P., Jarzyna, P. A., Delshad, A., Blachford, C., Barazza, A., Fisher, E. A., Gordon, R. E., Fayad, Z. A., & Mulder, W. J. M. (2011) · Biomaterials

Nanoparticle-Based Drug DeliveryCharacterization and Applications of Magnetic Nanoparticles

Cited by 69

miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques

Afonso, M. S., Sharma, M., Schlegel, M., van Solingen, C., Koelwyn, G. J., Shanley, L. C., Beckett, L., Peled, D., Rahman, K., Giannarelli, C., et al. (2021) · Circulation Research

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 53

Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low‐density lipoprotein receptor

Elder, G. A., Cho, J. Y., English, D. F., Franciosi, S., Schmeidler, J., Sosa, M. A. G., Gasperi, R. D., Fisher, E. A., Mathews, P. M., Haroutunian, V., et al. (2007) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism

Cited by 26

Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells

Maitin, V., Andreo, U., Guo, L., & Fisher, E. A. (2014) · Journal of Lipid Research

Fatty Acid Research and HealthCholesterol and Lipid Metabolism

Cited by 14

Clonal Expansion in Cardiovascular Pathology

Lin, A., Brittan, M., Baker, A. H., Dimmeler, S., Fisher, E. A., Sluimer, J. C., & Misra, A. (2024) · JACC: Basic to Translational Science

Atherosclerosis and Cardiovascular DiseasesAngiogenesis and VEGF in Cancer

Cited by 13